Skip to main content
. 2020 Oct 8;20:260. doi: 10.1186/s12890-020-01278-5

Fig. 5.

Fig. 5

Effects of lung perfusion with and without 50 nM of the Kv3.4 inhibitor BDS-I on hypoxia induced vasoconstriction expressed as increase mmHg of baseline perfusion pressure (ΔPAP) in lungs obtained from LPS-treated (■) and untreated control (□) mice (*p < 0.05 vs. control; # p < 0.05 versus LPS without BDS-I; n = 7 per group, means ± SEM)